Cargando…

Very Late Antigen-4 (α(4)β(1) Integrin) Targeted PET Imaging of Multiple Myeloma

Biomedical imaging techniques such as skeletal survey and (18)F-fluorodeoxyglucose (FDG)/Positron Emission Tomography (PET) are frequently used to diagnose and stage multiple myeloma (MM) patients. However, skeletal survey has limited sensitivity as it can detect osteolytic lesions only after 30–50%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soodgupta, Deepti, Hurchla, Michelle A., Jiang, Majiong, Zheleznyak, Alexander, Weilbaecher, Katherine N., Anderson, Carolyn J., Tomasson, Michael H., Shokeen, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568146/ https://www.ncbi.nlm.nih.gov/pubmed/23409060 http://dx.doi.org/10.1371/journal.pone.0055841

Ejemplares similares

Correction: Very Late Antigen-4 (α(4)β(1) Integrin) Targeted PET Imaging of Multiple Myeloma
por: Soodgupta, Deepti, et al.
Publicado: (2013)

Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
por: Hurchla, Michelle A., et al.
Publicado: (2012)

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins
Publicado: (1995)

Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis
por: Zhu, Qin, et al.
Publicado: (2023)

Very late antigen 4-dependent adhesion and costimulation of resting human T cells by the bacterial beta 1 integrin ligand invasin
Publicado: (1993)

Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms
Publicado: (1995)

The heat-stable antigen can alter very late antigen 4-mediated adhesion
Publicado: (1994)

Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types
por: Amend, Sarah R., et al.
Publicado: (2015)

Lymphocyte function-associated antigen 1 dominates very late antigen 4 in binding of activated T cells to endothelium
Publicado: (1993)

Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles
por: Swart, Laura E., et al.
Publicado: (2023)

A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo
Publicado: (1993)

Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
Publicado: (1994)

Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium
Publicado: (1992)

Integrins in multiple myeloma
por: Hosen, Naoki
Publicado: (2020)

Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation
Publicado: (1996)

Very Late Antigen-4: A Novel Receptor for Club Cell Secretory Protein 16 to Control Inflammation
por: Chu, Hong Wei, et al.
Publicado: (2021)

Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
por: Steri, Veronica, et al.
Publicado: (2013)

Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands
Publicado: (1995)

B‐cell very late antigen‐4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity
por: Lehmann‐Horn, Klaus, et al.
Publicado: (2015)

The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis
por: Oliveira, Vanessa, et al.
Publicado: (2019)

The Interaction Affinity between Vascular Cell Adhesion Molecule-1 (VCAM-1) and Very Late Antigen-4 (VLA-4) Analyzed by Quantitative FRET
por: Chakraborty, Sandeep, et al.
Publicado: (2015)

Real-time Analysis of the Inside-out Regulation of Lymphocyte Function-associated Antigen-1 Revealed Similarities to and Differences from Very Late Antigen-4
por: Chigaev, Alexandre, et al.
Publicado: (2011)

Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery
por: Pan, Dipanjan, et al.
Publicado: (2016)

Very late activation antigens (VLA) are human leukocyte-neuronal crossreactive cell surface antigens
Publicado: (1986)

Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinoma
por: Malone, Christopher D., et al.
Publicado: (2022)

Downregulation of Integrin β4 Decreases the Ability of Airway Epithelial Cells to Present Antigens
por: Liu, Chi, et al.
Publicado: (2012)

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
por: Hathi, Deep, et al.
Publicado: (2022)

Regulation of miRNA expression by α4β1 integrin‐dependent multiple myeloma cell adhesion
por: Rodríguez‐García, Yaiza, et al.
Publicado: (2023)

Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma
por: Cho, Nicholas, et al.
Publicado: (2021)

Purpose in Life: A Reconceptualization for Very Late Life
por: Anderson, Keith, et al.
Publicado: (2021)

Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
Publicado: (1994)

The Small Tellurium Compound AS101 Ameliorates Rat Crescentic Glomerulonephritis: Association with Inhibition of Macrophage Caspase-1 Activity via Very Late Antigen-4 Inactivation
por: Hachmo, Yafit, et al.
Publicado: (2017)

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [(18)F]FDG and [(64)Cu]Cu-LLP2A PET
por: Ghai, Anchal, et al.
Publicado: (2021)

Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies
por: Altrock, Philipp M., et al.
Publicado: (2018)

Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer
por: Kotagiri, Nalinikanth, et al.
Publicado: (2018)

Identification of CD8(+) T-cell epitope from multiple myeloma-specific antigen AKAP4
por: Ma, Ning, et al.
Publicado: (2022)

Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages
por: Getts, Daniel R, et al.
Publicado: (2012)

Interest of Pet Imaging in Multiple Myeloma
por: Jamet, Bastien, et al.
Publicado: (2019)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Multiple myeloma in the very elderly patient: challenges and solutions
por: Willan, John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_es7gr2jjus3ama4iapkkor3el5